OnPoint Surgical Appoints Jeremy Laynor as Chief Commercial Officer to Drive Global Expansion
Boston-based OnPoint Surgical has appointed Jeremy Laynor as Chief Commercial Officer to support the company’s international growth and accelerate commercialization of its augmented reality and artificial intelligence (AR-AI) surgical guidance technologies. Laynor brings more than 20 years of leadership experience across the medical device, software, and health technology sectors, with a strong record of scaling commercial operations and driving global market expansion.
Before joining OnPoint, Laynor served as Senior Vice President of Global Sales at Providence Medical Technology, where he led a high-performing sales organization and expanded the company’s international distribution network, resulting in significant revenue growth. His previous roles at Paradigm Spine, Medtronic, and Cardinal Health included developing global sales strategies, leading surgeon education programs, and advancing innovative business models for ambulatory surgery centers.
“Jeremy is an exceptional commercial leader whose deep expertise in orthopedic and spine markets, coupled with his proven ability to scale global sales organizations, will be transformative as OnPoint advances commercialization of our AR-AI surgical guidance systems,” said Philipp Lang, M.D., CEO of OnPoint Surgical. “His leadership will be critical as we expand into new surgical applications and broaden adoption.”
Laynor said he was drawn to the company’s technology and mission, commenting, “OnPoint’s AR-AI technology represents a paradigm shift in surgical precision, safety, and efficiency. I am thrilled to join the OnPoint team to accelerate commercialization and deliver this groundbreaking platform to surgeons and patients.”
OnPoint Surgical and its affiliated companies—OnPoint Medical, OnPoint Knee, OnPoint Hip, and OnPoint Sports—are developing AR and AI guidance technologies across a wide range of surgical specialties, including spinal, neurosurgical, orthopedic, arthroscopic, and robotic procedures. The company holds more than 50 granted patents across the U.S., China, and the EU, establishing a leading intellectual property position in AR-guided surgical navigation.
